BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26951679)

  • 1. Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.
    Dai W; Zheng H; Cheung AK; Tang CS; Ko JM; Wong BW; Leong MM; Sham PC; Cheung F; Kwong DL; Ngan RK; Ng WT; Yau CC; Pan J; Peng X; Tung S; Zhang Z; Ji M; Chiang AK; Lee AW; Lee VH; Lam KO; Au KH; Cheng HC; Yiu HH; Lung ML
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3317-22. PubMed ID: 26951679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.
    Yu G; Hsu WL; Coghill AE; Yu KJ; Wang CP; Lou PJ; Liu Z; Jones K; Vogt A; Wang M; Mbulaiteye SM; Chen HH; Boland J; Yeager M; Diehl SR; Chen CJ; Hildesheim A; Goldstein AM
    Sci Rep; 2019 Jul; 9(1):9916. PubMed ID: 31289279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
    Dai W; Zheng H; Cheung AK; Lung ML
    Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Exome Sequencing Study of Familial Nasopharyngeal Carcinoma and Its Implication for Identifying High-Risk Individuals.
    Wang TM; He YQ; Xue WQ; Zhang JB; Xia YF; Deng CM; Zhang WL; Xiao RW; Liao Y; Yang DW; Zhou T; Li DH; Luo LT; Tong XT; Wu YX; Chen XY; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Wang F; Wu ZY; Zheng MQ; Huang JW; Jia YJ; Yuan LL; You R; Zhou GQ; Lu LX; Liu YY; Chen MY; Feng L; Dai W; Ren ZF; Mai HQ; Sun Y; Ma J; Zheng W; Lung ML; Jia WH
    J Natl Cancer Inst; 2022 Dec; 114(12):1689-1697. PubMed ID: 36066420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
    Sasaki MM; Skol AD; Bao R; Rhodes LV; Chambers R; Vokes EE; Cohen EE; Onel K
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1222-8. PubMed ID: 26014803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication.
    Xiao RW; Wang F; Wang TM; Zhang JB; Wu ZY; Deng CM; Liao Y; Zhou T; Yang DW; Dong SQ; Xue WQ; He YQ; Zheng XH; Li XZ; Zhang PF; Zhang SD; Hu YZ; Liu YY; Xia YF; Gao S; Mu JB; Feng L; Jia WH
    EBioMedicine; 2022 Oct; 84():104267. PubMed ID: 36116213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection.
    Yang L; Liu B; Qiu F; Huang B; Li Y; Huang D; Yang R; Yang X; Deng J; Jiang Q; Zhou Y; Lu J
    Carcinogenesis; 2014 Jan; 35(1):46-52. PubMed ID: 24056810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to the endemic form of NPC.
    Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
    Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
    Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological factors of nasopharyngeal carcinoma.
    Tsao SW; Yip YL; Tsang CM; Pang PS; Lau VM; Zhang G; Lo KW
    Oral Oncol; 2014 May; 50(5):330-8. PubMed ID: 24630258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
    Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
    J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma.
    Bei JX; Jia WH; Zeng YX
    Semin Cancer Biol; 2012 Apr; 22(2):96-106. PubMed ID: 22313875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC.
    Liu Z; Goldstein AM; Hsu WL; Yu KJ; Chien YC; Ko JY; Jian JJ; Tsou YA; Leu YS; Liao LJ; Chang YL; Wang CP; Wu JS; Hua CH; Lee JC; Yang TL; Hsiao CK; Wu MS; Tsai MH; Huang KK; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou PJ; Chen CJ; Hildesheim A;
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1682-1686. PubMed ID: 31270100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
    Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
    Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
    Zheng J; Liu B; Zhang L; Jiang L; Huang B; You Y; Jiang Q; Zhang S; Lu J; Zhou Y
    Int J Cancer; 2012 May; 130(9):1981-90. PubMed ID: 21702039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
    Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
    Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.